Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline https://financefeeds.com/24-exchange-and-blue-ocean-celebrate-dtccs-extended-clearing-hours/